Abstract
New information is available to improve antibiotic outcomes in severe sepsis where increasing resistance and reducing novel compound development make reaching the right decisions ever more difficult and important.
| Original language | English |
|---|---|
| Pages (from-to) | 437-41 |
| Number of pages | 5 |
| Journal | British Journal of Hospital Medicine |
| Volume | 71 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2010 |
| Externally published | Yes |
Keywords
- Anti-Bacterial Agents
- Biofilms
- Cost-Benefit Analysis
- Decision Making
- Drug Administration Schedule
- Drug Resistance, Microbial
- Humans
- Practice Guidelines as Topic
- Journal Article